4//SEC Filing
Jenne Kyle 4
Accession 0001209191-20-051891
CIK 0001662524other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:21 PM ET
Size
4.8 KB
Accession
0001209191-20-051891
Insider Transaction Report
Form 4
Jenne Kyle
Chief Commercial Officer
Transactions
- Sale
Common Stock
2020-09-22$18.12/sh−720$13,046→ 52,012 total
Footnotes (1)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001791857
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:21 PM ET
- Size
- 4.8 KB